Xi'an Triangle Defense (300775)2022-10-24 16:00Financial Performance - The company's revenue for Q3 2022 reached ¥551,006,319.74, representing an increase of 84.42% compared to the same period last year[7] - Net profit attributable to shareholders for Q3 2022 was ¥167,554,227.94, up 51.51% year-over-year[7] - The net profit after deducting non-recurring gains and losses was ¥164,034,022.85, reflecting a 47.54% increase compared to the previous year[7] - The company's basic earnings per share for Q3 2022 was ¥0.34, reflecting a 54.55% increase compared to the same period last year[7] - The total profit for the current period was ¥544,677,123.76, reflecting a 71.16% increase from the previous period[16] - Net profit for the current period was ¥468,677,595.69, a 69.98% increase from the previous period's ¥275,720,327.84[16] - Total operating revenue for the current period reached ¥1,462,747,079.63, a significant increase from ¥765,502,642.06 in the previous period, representing an increase of approximately 91%[40] - Total operating costs amounted to ¥870,361,584.64, up from ¥450,442,402.44, reflecting a growth of about 93%[40] - Basic earnings per share rose to ¥0.94 from ¥0.56, marking a growth of about 68%[43] Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥5,120,740,566.44, a growth of 23.95% from the end of the previous year[7] - The total liabilities increased significantly, with accounts payable rising by 43.46% to ¥565,160,311.26 due to increased orders and raw material procurement[16] - The company's total liabilities as of September 30, 2022, were approximately 2.23 billion RMB, up from approximately 1.67 billion RMB at the beginning of the year, indicating an increase of about 33%[36] - The total equity attributable to shareholders increased by 17.57% to ¥2,888,349,108.15 compared to the end of the previous year[7] - The company's total equity reached approximately 2.89 billion RMB as of September 30, 2022, compared to approximately 2.46 billion RMB at the beginning of the year, marking an increase of about 17.5%[36] Cash Flow - Cash flow from operating activities for the year-to-date was ¥59,207,125.54, showing a decline of 66.52% year-over-year[7] - The company's cash and cash equivalents net increase was negative at -¥35,408,923.02, a decline of 104.21% compared to the previous period[16] - Cash inflow from investment activities was ¥205,965,568.42, while cash outflow was ¥432,185,232.64, resulting in a net cash flow of -¥226,219,664.22[47] - Cash received from other financing activities was 1,000,000.00 previously[50] - Cash paid for dividends, profits, or interest amounted to 41,126,500.00 in the previous period[50] Operational Highlights - The company reported a significant increase in accounts receivable, which rose by 157.76% to ¥1,112,195,594.63, attributed to increased sales orders[13] - The company reported a significant increase in inventory, with total inventory reaching approximately 1.11 billion RMB as of September 30, 2022, compared to approximately 1.02 billion RMB at the beginning of the year, reflecting a growth of about 8.5%[33] - The company experienced a 30.72% increase in contract liabilities, amounting to ¥8,304,003.28, due to growth in advance payments received[16] - The company’s other payables surged by 25,879.83% to ¥80,852,571.79, mainly due to the increase in restricted stock compensation[16] Government and Regulatory Matters - The company received government subsidies amounting to ¥3,538,354.56 during the quarter, contributing to its non-recurring gains[8] - The company received a notice from the Shenzhen Stock Exchange on August 3, 2022, confirming the acceptance of its application for issuing shares to specific targets[29] - The company is currently awaiting approval from the China Securities Regulatory Commission for the issuance of shares to specific targets, which remains uncertain[30] Research and Development - Research and development expenses increased to ¥38,098,655.78 from ¥31,650,039.78, reflecting a growth of about 20%[40] Other Information - The company completed the first grant registration of the 2022 restricted stock incentive plan on July 15, 2022, with a total of 3.68 million shares granted at a price of 21.92 RMB per share[26] - The third quarter report was not audited[51]